A randomized, double blind, vehicle-controlled multicenter phase III study to evaluate the safety and efficacy of BF-200 ALA and narrowband red light in the treatment of superficial basal cell carcinoma (sBCC) with photodynamic therapy (PDT)

Abstract not available.

Follow-up results of a randomized, double-blind, phase III, multi-center study to evaluate the safety and efficacy of BF-200 ALA versus placebo in field-directed treatment of mild to moderate AK with photodynamic therapy when using narrowband red light

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.3.supp.49 ◽

2019 ◽

Vol 3 ◽

pp. S49

Author(s):

U Reinhold ◽

T Dirschka ◽

R Ostendorf ◽

R Aschoff ◽

C Berking ◽

...

Keyword(s):

Photodynamic Therapy ◽

Red Light ◽

Phase Iii ◽

Double Blind ◽

Safety And Efficacy ◽

Multi Center Study ◽

Center Study

Abstract not available.

Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe

10.1111/j.1365-2133.2005.06486.x ◽

2005 ◽

Vol 152 (5) ◽

pp. 939-947 ◽

Cited By ~ 157

Author(s):

H.J. Schulze ◽

B. Cribier ◽

L. Requena ◽

J. Reifenberger ◽

C. Ferrandiz ◽

...

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Phase Iii ◽

Phase Iii Study ◽

A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy

10.1111/bjd.16441 ◽

2018 ◽

Cited By ~ 9

Author(s):

C.A. Morton ◽

R. Dominicus ◽

P. Radny ◽

T. Dirschka ◽

A. Hauschild ◽

...

Keyword(s):

Photodynamic Therapy ◽

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Phase Iii ◽

Phase Iii Trial ◽

Safety And Efficacy ◽

Aminolaevulinic Acid ◽

Acid Gel

RAD001 vs placebo in patients with metastatic renal cell carcinoma (RCC)after progression on VEGFr-TKI therapy: Results from a randomized, double-blind, multicenter Phase-III study

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.lba5026 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. LBA5026-LBA5026 ◽

Cited By ~ 33

Author(s):

R. J. Motzer ◽

B. Escudier ◽

S. Oudard ◽

C. Porta ◽

T. E. Hutson ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Phase Iii ◽

Double Blind ◽

Multicenter Phase ◽

Phase Iii Study

Immunocryosurgery for Non-superficial Basal Cell Carcinoma: A Prospective, Open-label Phase III Study for Tumours ≤ 2 cm in Diameter

Acta Dermato Venereologica ◽

10.2340/00015555-1609 ◽

2014 ◽

Vol 94 (1) ◽

pp. 38-44 ◽

Cited By ~ 13

Author(s):

G Gaitanis ◽

I Bassukas

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Phase Iii ◽

Open Label ◽

Open Label Phase ◽

Phase Iii Study ◽

Faculty Opinions recommendation of Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718016210.793479146 ◽

2013 ◽

Author(s):

Melvin Chiu

Keyword(s):

Photodynamic Therapy ◽

Randomised Controlled Trial ◽

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Controlled Trial ◽

Topical Imiquimod ◽

Superficial Basal Cell Carcinoma ◽

Randomised Controlled ◽

Single Blind

Faculty Opinions recommendation of A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718844198.793505941 ◽

2015 ◽

Author(s):

John Carucci

Keyword(s):

Photodynamic Therapy ◽

Clinical Study ◽

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Methyl Aminolevulinate ◽

Response to ‘Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial: a critical appraisal’

10.1111/bjd.13565 ◽

2015 ◽

Vol 172 (1) ◽

pp. 11-12

Author(s):

A. Arits ◽

P. Nelemans ◽

N. Kelleners-Smeets

Keyword(s):

Photodynamic Therapy ◽

Randomised Controlled Trial ◽

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Critical Appraisal ◽

Controlled Trial ◽

Superficial Basal Cell Carcinoma ◽

Randomised Controlled ◽

Single Blind

Comparison of Fixed-dose Combinations of Amlodipine/Losartan Potassium/Chlorthalidone and Amlodipine/Losartan Potassium in Patients With Stage 2 Hypertension Inadequately Controlled With Amlodipine/Losartan Potassium: A Randomized, Double-blind, Multicenter, Phase III Study

Clinical Therapeutics ◽

10.1016/j.clinthera.2017.08.013 ◽

2017 ◽

Vol 39 (10) ◽

pp. 2049-2060 ◽

Cited By ~ 2

Author(s):

Soon Jun Hong ◽

Han Saem Jeong ◽

Seung Hwan Han ◽

Ki Yuk Chang ◽

Bum Kee Hong ◽

...

Keyword(s):

Phase Iii ◽

Losartan Potassium ◽

Fixed Dose ◽

Double Blind ◽

Multicenter Phase ◽

Phase Iii Study

Photodynamic therapy vs. topical imiquimod for treatment of superficial basal cell carcinoma: a subgroup analysis within a noninferiority randomized controlled trial

10.1111/bjd.13299 ◽

2014 ◽

Vol 172 (3) ◽

pp. 739-745 ◽

Cited By ~ 23

Author(s):

M.H. Roozeboom ◽

P.J. Nelemans ◽

K. Mosterd ◽

P.M. Steijlen ◽

A.H.M.M. Arits ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Photodynamic Therapy ◽

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Subgroup Analysis ◽

Controlled Trial ◽

Randomized Controlled ◽

Topical Imiquimod ◽